Skip to Main Content

Author Details

Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
2001
369
65
PMIDPaper TitleJournal TitlePublished Year
37750346Evaluating equity of access and predictors of minimally invasive hysterectomy for endometrial and cervical cancer from 2000 to 2017 in Ontario, Canada: A population-based cohort study.J Surg Oncol2024
36241767A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment.J Cancer Surviv2023
37623034Trainee Evaluations of Preparedness for Clinical Trials in Medical Oncology-A National Questionnaire.Curr Oncol2023
37623016A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer.Curr Oncol2023
37552518Differentiating Specialized and Advanced Nursing Roles: The Pathway to Role Optimization.Nurs Leadersh (Tor Ont)2023
37585627Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.N Engl J Med2023
37479538Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis.J Geriatr Oncol2023
37681028The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada.Front Oncol2023
37563779Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.J Natl Cancer Inst2023
37190964Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort study.Am J Hematol2023
37146436Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study.Gynecol Oncol2023
37439357Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study.Haematologica2023
37000165SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.Clin Cancer Res2023
36592505Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.Eur J Cancer2023
36922304Regularly scheduled physical examinations and the detection of breast cancer recurrences.Breast2023
36652284Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial.J Med Internet Res2023
36610615BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy.Int J Radiat Oncol Biol Phys2023
36910062Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer.J Thorac Dis2023
36640100Rurality index score and pediatric neuro-oncological outcome in Ontario.J Neurosurg Pediatr2023
36604714Increasing palliative care capacity in primary care: study protocol of a cluster randomized controlled trial of the CAPACITI training program.BMC Palliat Care2023
36535850Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study.Clin Oncol (R Coll Radiol)2023
36765529Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer.Cancers (Basel)2023
36898363Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities.J Natl Compr Canc Netw2023
36826114Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study.Curr Oncol2023
35112212Vasomotor symptoms in early breast cancer-a "real world" exploration of the patient experience.Support Care Cancer2022
35614153Using machine learning to predict individual patient toxicities from cancer treatments.Support Care Cancer2022
35644731Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study.Gynecol Oncol2022
35526835Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.J Mol Diagn2022
35420329Lack of cognitive impairment in long-term survivors of colorectal cancer.Support Care Cancer2022
36547123Chemo-Immunotherapy in First Line Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Review and Meta-Analysis.Curr Oncol2022
36659968Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma.Neurooncol Pract2022
35965204Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer.Clin Breast Cancer2022
35987988Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial.J Exp Clin Cancer Res2022
36192238Disparities in the survival of endometrial cancer patients in a public healthcare system: A population-based cohort study.Gynecol Oncol2022
35248391The impact of preoperative imaging on wait times, surgical approach and overall survival in endometrioid endometrial cancers.Gynecol Oncol2022
34940805Metformin-A Thought-provoking Addition to Anticancer Therapies-Reply.JAMA Oncol2022
35087029Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study.Blood Cancer J2022
35059864Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers.Support Care Cancer2022
35266952Biased Evaluation in Cancer Drug Trials-How Use of Progression-Free Survival as the Primary End Point Can Mislead.JAMA Oncol2022
35113918A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer.PLoS One2022
33023785A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.Eur J Cancer2021
33909949Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.BJU Int2021
33680749Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation.J Bone Oncol2021
33901921A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia.Breast2021
33538782Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.JAMA Oncol2021
33755864Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey.Breast Cancer Res Treat2021
33667493Risk Perception Among a Lung Cancer Screening Population.Chest2021
33839738External validation of the FIRST trial's simplified frailty score in a population-based cohort.Leukemia2021
33559097Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study.J Gastrointest Surg2021
33750604The use of imaging in endometrial cancer prior to potential surgery: Are guidelines being followed?Gynecol Oncol2021
  • 1 - 50 of 369

Recommended Authors

Holly E Hartman
Case Western Reserve University
Career Start Year 2018
Number of shared co-authors 1
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 8
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 22
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 4
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 14
Angelina D Tan
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 1
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 5
Qian Shi
117902Beijing TongRen Hospital, Capital Medical University
Career Start Year 2004
Number of shared co-authors 3
Nora Horick
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 2
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 22
Brian A Costello
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 6
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 8
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 3
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 21
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 9
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 6
Deborah Schrag
Memorial-Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 10
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 5
Laurence Collette
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 12
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 7
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 40
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 3
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 3
Vera J Suman
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 3
Urban Emmenegger
Odette Cancer Centre
Career Start Year 1991
Number of shared co-authors 19
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 15
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 6

Collaborators

Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 41
Matthew D Galsky
Co-authored papers 20
Mark N Levine
Juravinski Hospital and Cancer Center
Co-authored papers 17
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 14
Neeraj Agarwal
Co-authored papers 12
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 11
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 10
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 9
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 9
Ronald de Wit
Erasmus MC Cancer Institute
Co-authored papers 9
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 7
Masoom A Haider
University Health Network
Co-authored papers 7
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers 7
Sharon F McGee
The Ottawa Hospital Cancer Centre
Co-authored papers 6
James Ho
Co-authored papers 5
Stephanie A Wankowicz
University of California San Francisco
Co-authored papers 5
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 5
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 4
William R Berry
Duke Cancer Center Cary
Co-authored papers 4
Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers 4
Clement Ma
Co-authored papers 4
Cynthia S Crowson
Co-authored papers 4
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Syed A Hussain
University of Sheffield and Sheffield Teaching Hospitals
Co-authored papers 4
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 4
Ants Toi
Mount Sinai Hospital, University of Toronto
Co-authored papers 4
Rebecca Nagy
Guardant Health Inc.
Co-authored papers 3
Marcela Gronda
Princess Margaret Cancer Centre
Co-authored papers 3
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 3
Release 1.2